⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANRO News
Alto Neuroscience Inc.
Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
businesswire.com
ANRO
Global Surgical Robotic Systems Market is Set to Reach USD 30 Billion by 2034 Due to the Rising Demand for Precision Surgery | DelveInsight
prnewswire.com
ISRG
STX
JNJ
MDT
GMED
ZBH
ABT
BSX
ANRO
BIIB
GEHC
GOOG
MSFT
IBM
AMZN
AAPL
TSLA
CData Expands Connect AI Platform with New Agent Tooling and Enterprise-Grade Security to Power Production AI Deployments
prnewswire.com
MSFT
ANRO
DBX
GOOG
PLTR
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
prnewswire.com
HELP
AXSM
RLMD
ANRO
CMPS
BREAKER RAISES $6M IN SEED ROUND TO SOLVE DEFENSE'S AUTONOMOUS ORCHESTRATION PROBLEM
prnewswire.com
RKLB
ANRO
SHOP
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
businesswire.com
ANRO
Vascular Access Device Market worth $8.68 billion by 2031 | MarketsandMarkets™
prnewswire.com
BDX
TFX
ICUI
ANRO
MMSI
MCI
CCK
Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment
businesswire.com
ANRO
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Replimune Group, Inc. (REPL), and Fly-E Group, Inc. (FLYE)
globenewswire.com
ANRO
ATKR
REPL
FLYE
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
businesswire.com
ANRO